Study of treatment for pyoderma gangrenosum patients.
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Ciclosporin (Primary) ; Prednisolone (Primary)
- Indications Pyoderma gangrenosum
- Focus Therapeutic Use
- Acronyms STOP-GAP
- 22 Jun 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
- 07 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 05 Dec 2012 Accrual to date is 135% according to United Kingdom Clinical Research Network record.